An analysis of frailty and multimorbidity in 20,566 UK Biobank participants with type 2 diabetes

BACKGROUND: Frailty and multimorbidity are common in type 2 diabetes (T2D), including people <65 years. Guidelines recommend adjustment of treatment targets in people with frailty or multimorbidity. It is unclear how recommendations to adjust treatment targets in people with frailty or multimorbi...

Descripción completa

Detalles Bibliográficos
Autores principales: Hanlon, Peter, Jani, Bhautesh D., Butterly, Elaine, Nicholl, Barbara, Lewsey, Jim, McAllister, David A., Mair, Frances S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9053176/
https://www.ncbi.nlm.nih.gov/pubmed/35602215
http://dx.doi.org/10.1038/s43856-021-00029-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9053176/
https://www.ncbi.nlm.nih.gov/pubmed/35602215
http://dx.doi.org/10.1038/s43856-021-00029-9

Ejemplares similares